Table of Contents
This 103-page report is designed to help suppliers identify and evaluate emerging opportunities for further automating NAT methods in order to facilitate their penetration into the routine clinical laboratory market. Some instrumentation is already available on the market, e.g., DNA extractors, DNA synthesizers, thermal cyclers, robotic work-stations, and automated DNA probe analysis systems. The report reviews current instrumentation technologies, and compares features of leading molecular diagnostics analyzers marketed by Abbott, Beckman Coulter, BD, Bio-Rad, Gen-Probe, Tecan, Trinity Biotech and other manufacturers.
This report also presents strategic assessments of current and emerging suppliers of NAT products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Contains 103 pages
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
This new 31-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as ...
Complete report $34,500. DataPack (test volumes, sales forecasts, supplier shares) $21,100. The report is available by country, section, market segment, and can be custom-tailored to your specific ...
Complete report $34,750. DataPack (test volumes, sales forecasts, supplier shares) $21,100. The report is available by country, section, market segment, and can be custom-tailored to your specific ...